Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Armand

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review CommitteeC Lardot, W Steward, M Van Glabbeke, et al.
Bulletin Du Cancer|January 1, 1977
[Evaluation of the results of radiotherapy in 14 cases of malignant thymoma. Therapeutic prospects]A Pons, J P Armand, J J Voigt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A new anticancer agent (LY186641) interferes with creatinine assayM M Bonnay, G Recondo, A J Gouyette, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemiaG Recondo, M Benhamed, E Cvitkovic, et al.
Pathologie-Biologie|April 1, 1984
[Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis]P Canal, G Villeneuve, R Bugat, et al.
Annales De Genetique|January 1, 1988
[The 48,XXXX syndrome: study of psychomotor development from birth to 11 years of age and review of the literature]H Plauchu, E Ollagnon-Roman, J P Armand, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Specificity of the phase I trial for cytotoxic drugs in oncologyJ P Armand, M Klink-Alakl, G Recondo, et al.
Bulletin Du Cancer|January 1, 1996
[Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials]C Couteau, K Yakendji, C Terret, et al.
Revue Francaise Des Maladies Respiratoires|January 1, 1981
[Cerebral irradiation as adjuvant therapy in the treatment of small cell carcinoma of the lung (author's transl)]T D N'Guyen, A Pons, J P Armand, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humansM C Malet-Martino, J Bernadou, R Martino, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review CommitteeC Lardot, W Steward, M Van Glabbeke, et al.
Bulletin Du Cancer|January 1, 1977
[Evaluation of the results of radiotherapy in 14 cases of malignant thymoma. Therapeutic prospects]A Pons, J P Armand, J J Voigt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A new anticancer agent (LY186641) interferes with creatinine assayM M Bonnay, G Recondo, A J Gouyette, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemiaG Recondo, M Benhamed, E Cvitkovic, et al.
Pathologie-Biologie|April 1, 1984
[Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis]P Canal, G Villeneuve, R Bugat, et al.
Annales De Genetique|January 1, 1988
[The 48,XXXX syndrome: study of psychomotor development from birth to 11 years of age and review of the literature]H Plauchu, E Ollagnon-Roman, J P Armand, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Specificity of the phase I trial for cytotoxic drugs in oncologyJ P Armand, M Klink-Alakl, G Recondo, et al.
Bulletin Du Cancer|January 1, 1996
[Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials]C Couteau, K Yakendji, C Terret, et al.
Revue Francaise Des Maladies Respiratoires|January 1, 1981
[Cerebral irradiation as adjuvant therapy in the treatment of small cell carcinoma of the lung (author's transl)]T D N'Guyen, A Pons, J P Armand, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humansM C Malet-Martino, J Bernadou, R Martino, et al.
Pageof 15